世界の骨成長刺激装置の市場規模は、2021年の11億ドルから2026年までに15億ドルに達し、予測期間中のCAGRは5.8％と予想されます。骨成長刺激装置市場の成長を促す要因としては、患者が非侵襲的および低侵襲的外科治療を希望する傾向が強いこと、対象疾患の有病率の上昇、スポーツおよび事故関連の整形外科的損傷の増加などが挙げられます。一方で、骨刺激装置に対する医療費の制約、BMPおよびPRP製品に関連する高額な治療費、BMPを用いた整形外科治療に関連する副作用が、この市場の成長を抑制する主な要因です。
世界的なCOVID-19のパンデミックは、医療、石油、航空＆防衛、食品＆飲料など、市場の複数のセクターと業種に大きな影響を与えています。これらの業界の大部分は、世界的な経済状況、ビジネスに対するパンデミックの地域的影響、政府の法律と予防規制、エンドユーザーからの需要、サプライチェーンやロジスティクスの観点から、直面する課題に関して不確実な状況に置かれています。その結果、主要企業と市場関係者は、長期的な成長戦略から短期的な持続可能性戦略に焦点を移すことを余儀なくされ、世界経済の特定のセクターにおける製造、供給、消費者コミュニケーションなどの事業運営に変化をもたらしました。
パンデミックは、待機的手術の急激な減少、組織化されたスポーツの禁止、O＆Pクリニックの一時的な閉鎖、非エッセンシャルケアに限定された病院へのアクセス、診療所、および入院患者の流れと紹介の減少などによって、骨成長刺激装置市場に短期的な影響を与えることが予想されます。ただし、中国だけでなくヨーロッパの主要市場でも徐々に回復の兆しが見られます。COVID以前の待機的手術への対応、未処理分や新規症例の解消による手術数の増加、完全に再開された医療、大規模に再開されたレクリエーションや身体的作業、団体スポーツの再開、などによって、市場は2021年後半から予想通り徐々に上昇し始めることが期待されます。さらに、高齢者人口の増加や糖尿病、肥満、変形性関節症の有病率の上昇などの長期的な成長要因が、予測期間中に引き続き市場の成長に大きな役割を果たすでしょう。
目次
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 25)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY USED FOR THE STUDY
1.4.1 STANDARD CURRENCY CONVERSION RATES
1.5 LIMITATIONS
1.6 MARKET STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 30)
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 KEY DATA FROM SECONDARY SOURCES
2.1.2 PRIMARY RESEARCH
FIGURE 2 KEY DATA FROM PRIMARY SOURCES
FIGURE 3 KEY INDUSTRY INSIGHTS
FIGURE 4 BREAKDOWN OF SUPPLY-SIDE PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 5 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
2.2 MARKET ESTIMATION METHODOLOGY
2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
2.2.2 PRODUCT-BASED MARKET ESTIMATION
FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.2.3 PRIMARY RESEARCH VALIDATION
2.3 COVID-19 HEALTH ASSESSMENT
2.4 COVID-19 ECONOMIC ASSESSMENT
2.5 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
FIGURE 7 CRITERIA IMPACTING THE GLOBAL ECONOMY
FIGURE 8 RECOVERY SCENARIO OF THE GLOBAL ECONOMY
2.6 DATA TRIANGULATION
FIGURE 9 DATA TRIANGULATION
2.7 RESEARCH ASSUMPTIONS
2.8 RESEARCH LIMITATIONS
3 EXECUTIVE SUMMARY (Page No. - 45)
FIGURE 10 BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
FIGURE 11 BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
FIGURE 12 BONE GROWTH STIMULATORS MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
FIGURE 13 GEOGRAPHICAL SNAPSHOT OF THE BONE GROWTH STIMULATORS MARKET
4 PREMIUM INSIGHTS (Page No. - 49)
4.1 BONE GROWTH STIMULATORS MARKET OVERVIEW
FIGURE 14 RISING PREVALENCE OF ORTHOPEDIC DISORDERS TO DRIVE MARKET GROWTH
4.2 BONE GROWTH STIMULATORS MARKET SHARE, BY END USER, 2021 VS. 2026
FIGURE 15 HOSPITALS & ASCS SEGMENT WILL CONTINUE TO DOMINATE THE BONE GROWTH STIMULATORS MARKET IN 2026
4.3 ASIA PACIFIC: BONE GROWTH STIMULATORS MARKET, BY PRODUCT & COUNTRY (2020)
FIGURE 16 BONE GROWTH STIMULATION DEVICES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE APAC MARKET IN 2020
4.4 BONE GROWTH STIMULATORS MARKET, BY REGION, 2021?2026
FIGURE 17 APAC MARKET TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 53)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 MAJOR MARKET DRIVERS
5.2.1.1 Growing patient preference for noninvasive and minimally invasive surgical treatments
5.2.1.2 Increasing target patient population
FIGURE 18 OBESE POPULATION (AS A PERCENTAGE OF THE TOTAL POPULATION) IN OECD COUNTRIES (2017)
5.2.1.3 Rising number of sports and accident-related orthopedic injuries
FIGURE 19 INJURIES CAUSED BY VARIOUS SPORTS ACTIVITIES IN THE US (2019)
FIGURE 20 JAPAN REPORTED THE HIGHEST NUMBER OF ROAD ACCIDENTS GLOBALLY (2019)
5.2.2 MAJOR MARKET RESTRAINTS
5.2.2.1 Limited medical reimbursement for bone stimulation products
5.2.2.2 High treatment costs associated with BMP and PRP products
5.2.2.3 Limited clinical evidence to support the therapeutic efficacy of bone growth stimulators
5.2.3 MAJOR MARKET OPPORTUNITIES
5.2.3.1 Emerging markets
5.2.4 MAJOR MARKET CHALLENGES
5.2.4.1 Side effects associated with BMP-based orthopedic treatment
TABLE 1 CLINICAL SIDE EFFECTS ASSOCIATED WITH BMP-2
TABLE 2 PRECLINICAL SIDE EFFECTS WITH BMP-2 (IN VITRO AND IN VIVO)
5.3 PORTER’S FIVE FORCES ANALYSIS
5.3.1 OVERVIEW
TABLE 3 BONE GROWTH STIMULATORS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.3.2 THREAT OF NEW ENTRANTS
FIGURE 21 THREAT OF NEW ENTRANTS
5.3.3 THREAT OF SUBSTITUTES
FIGURE 22 THREAT OF SUBSTITUTES
5.3.4 BARGAINING POWER OF SUPPLIERS
FIGURE 23 BARGAINING POWER OF SUPPLIERS
5.3.5 BARGAINING POWER OF BUYERS
FIGURE 24 BARGAINING POWER OF BUYERS
5.3.6 DEGREE OF COMPETITION
FIGURE 25 DEGREE OF COMPETITION
5.4 VALUE CHAIN ANALYSIS
FIGURE 26 VALUE CHAIN ANALYSIS—MAXIMUM VALUE IS ADDED DURING THE MANUFACTURING PHASE
5.5 SUPPLY CHAIN ANALYSIS
5.5.1 PROMINENT COMPANIES
5.5.2 SMALL & MEDIUM-SIZED ENTERPRISES
5.5.3 END USERS
FIGURE 27 SUPPLY CHAIN ANALYSIS
5.6 ECOSYSTEM ANALYSIS
5.7 REGULATORY ANALYSIS
5.7.1 NORTH AMERICA
5.7.1.1 US
TABLE 4 US FDA: MEDICAL DEVICE CLASSIFICATION
TABLE 5 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.7.1.2 Canada
TABLE 6 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
FIGURE 28 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES
5.7.2 EUROPE
FIGURE 29 EUROPE: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES (MDR)
5.7.3 ASIA PACIFIC
5.7.3.1 Japan
TABLE 7 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
5.7.3.2 China
TABLE 8 CHINA: CLASSIFICATION OF MEDICAL DEVICES
5.7.3.3 India
5.8 TECHNOLOGY ANALYSIS
5.9 PATENT DETAILS
FIGURE 30 PATENT ANALYSIS (JANUARY 2011-MARCH 2021)
5.10 COVID-19 IMPACT ON THE BONE GROWTH STIMULATORS MARKET
5.11 PRICING ANALYSIS
TABLE 9 PRICING ANALYSIS: BONE GROWTH STIMULATORS, 2019 (USD)
6 BONE GROWTH STIMULATORS MARKET, BY PRODUCT (Page No. - 78)
6.1 INTRODUCTION
TABLE 10 BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
6.2 BONE GROWTH STIMULATION DEVICES
TABLE 11 BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 12 BONE GROWTH STIMULATION DEVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
TABLE 13 BONE GROWTH STIMULATION DEVICES MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 14 BONE GROWTH STIMULATION DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
6.2.1 EXTERNAL BONE GROWTH STIMULATORS
TABLE 15 EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 16 EXTERNAL BONE GROWTH STIMULATORS MARKET, BY REGION, 2019-2026 (USD MILLION)
TABLE 17 EXTERNAL BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 18 EXTERNAL BONE GROWTH STIMULATORS MARKET, BY END USER, 2019-2026 (USD MILLION)
6.2.1.1 Pulsed electromagnetic field devices
6.2.1.1.1 Pulsed electromagnetic field devices to witness the highest growth in the external bone growth stimulators market
TABLE 19 PULSED ELECTROMAGNETIC FIELD DEVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
6.2.1.2 Combined magnetic field devices
6.2.1.2.1 Combined magnetic field devices are portable, battery-powered, and noninvasive
TABLE 20 COMBINED MAGNETIC FIELD DEVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
6.2.1.3 Capacitive coupling devices
6.2.1.3.1 Need for frequent battery replacement or recharge is a disadvantage associated with CC devices
TABLE 21 CAPACITIVE COUPLING DEVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
6.2.2 ULTRASONIC BONE GROWTH STIMULATORS
6.2.2.1 These stimulators are used in the treatment of nonunion bone fractures and failed arthrodesis
TABLE 22 HCPCS CODE
TABLE 23 ULTRASONIC BONE GROWTH STIMULATORS MARKET, BY REGION, 2019-2026 (USD MILLION)
TABLE 24 ULTRASONIC BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 25 ULTRASONIC BONE GROWTH STIMULATORS MARKET, BY END USER, 2019-2026 (USD MILLION)
6.2.3 IMPLANTED BONE GROWTH STIMULATORS
6.2.3.1 Implanted bone growth stimulators provide constant stimulation of the bone directly at the fracture site and increase patient compliance
TABLE 26 IMPLANTED BONE GROWTH STIMULATORS MARKET, BY REGION, 2019-2026 (USD MILLION)
TABLE 27 IMPLANTED BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 28 IMPLANTED BONE GROWTH STIMULATORS MARKET, BY END USER, 2019-2026 (USD MILLION)
6.3 BONE MORPHOGENETIC PROTEINS
6.3.1 BMP IS A SAFE AND EFFECTIVE ALTERNATIVE TO BONE GRAFTS
TABLE 29 BONE MORPHOGENETIC PROTEINS MARKET, BY REGION, 2019-2026 (USD MILLION)
TABLE 30 BONE MORPHOGENETIC PROTEINS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 31 BONE MORPHOGENETIC PROTEINS MARKET, BY END USER, 2019-2026 (USD MILLION)
6.4 PLATELET-RICH PLASMA
6.4.1 ADVANTAGES OF PRP OVER OTHER PRODUCTS USED IN BONE STIMULATION TO DRIVE MARKET GROWTH
TABLE 32 PLATELET-RICH PLASMA MARKET, BY REGION, 2019-2026 (USD MILLION)
TABLE 33 PLATELET-RICH PLASMA MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 34 PLATELET-RICH PLASMA MARKET, BY END USER, 2019-2026 (USD MILLION)
7 BONE GROWTH STIMULATORS MARKET, BY APPLICATION (Page No. - 96)
7.1 INTRODUCTION
TABLE 35 BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
7.2 SPINAL FUSION SURGERIES
7.2.1 SPINAL FUSION SURGERIES TO DOMINATE THE BONE GROWTH STIMULATORS MARKET
TABLE 36 BONE GROWTH STIMULATORS MARKET FOR SPINAL FUSION SURGERIES, BY REGION, 2019-2026 (USD MILLION)
7.3 DELAYED UNION & NONUNION BONE FRACTURES
7.3.1 NONUNION FRACTURES ARE ESTIMATED TO COST THE US HEALTHCARE SYSTEM USD 9.2 BILLION/YEAR
TABLE 37 BONE GROWTH STIMULATORS MARKET FOR DELAYED UNION & NONUNION BONE FRACTURES, BY REGION, 2019-2026 (USD MILLION)
7.4 ORAL & MAXILLOFACIAL SURGERIES
7.4.1 BMPS ARE USED IN ORAL & MAXILLOFACIAL SURGERIES TO FORM A BASE FOR THE DENTAL IMPLANT AND STRENGTHEN AND THICKEN DENTAL SITES
TABLE 38 BONE GROWTH STIMULATORS MARKET FOR ORAL & MAXILLOFACIAL SURGERIES, BY REGION, 2019-2026 (USD MILLION)
7.5 OTHER APPLICATIONS
TABLE 39 BONE GROWTH STIMULATORS MARKET FOR OTHER APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
8 BONE GROWTH STIMULATORS MARKET, BY END USER (Page No. - 102)
8.1 INTRODUCTION
TABLE 40 BONE GROWTH STIMULATORS MARKET, BY END USER, 2019-2026 (USD MILLION)
8.2 HOSPITALS & ASCS
8.2.1 HOSPITALS & ASCS ARE THE LARGEST & FASTEST-GROWING END USERS OF BONE GROWTH STIMULATORS
TABLE 41 BONE GROWTH STIMULATORS MARKET FOR HOSPITALS & ASCS, BY REGION, 2019-2026 (USD MILLION)
8.3 HOME CARE SETTINGS
8.3.1 AVAILABILITY OF REIMBURSEMENT AND INSURANCE COVERAGE TO SUPPORT MARKET GROWTH
TABLE 42 BONE GROWTH STIMULATORS MARKET FOR HOME CARE SETTINGS, BY REGION, 2019-2026 (USD MILLION)
8.4 ACADEMIC & RESEARCH INSTITUTES
8.4.1 GROWING RESEARCH ON BONE GROWTH STIMULATION PRODUCTS TO AID MARKET GROWTH
TABLE 43 BONE GROWTH STIMULATORS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2019-2026 (USD MILLION)
9 BONE GROWTH STIMULATORS MARKET, BY REGION (Page No. - 108)
9.1 INTRODUCTION
TABLE 44 BONE GROWTH STIMULATORS MARKET, BY REGION, 2019-2026 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 31 NORTH AMERICA: BONE GROWTH STIMULATORS MARKET SNAPSHOT
TABLE 45 NORTH AMERICA: BONE GROWTH STIMULATORS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 46 NORTH AMERICA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 47 NORTH AMERICA: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 48 NORTH AMERICA: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 49 NORTH AMERICA: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 50 NORTH AMERICA: BONE GROWTH STIMULATORS MARKET, BY END USER, 2019-2026 (USD MILLION)
9.2.1 US
9.2.1.1 High burden of sports-related injuries and the strong presence of market players will drive market growth in the US
TABLE 51 US: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 52 US: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 53 US: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Market growth is driven by the rising incidence of bone-related diseases
TABLE 54 CANADA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 55 CANADA: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 56 CANADA: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE,2019-2026 (USD MILLION)
9.3 EUROPE
TABLE 57 EUROPE: BONE GROWTH STIMULATORS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 58 EUROPE: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 59 EUROPE: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 60 EUROPE: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 61 EUROPE: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 62 EUROPE: BONE GROWTH STIMULATORS MARKET, BY END USER, 2019-2026 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Germany is the largest market for bone growth stimulators in Europe
TABLE 63 GERMANY: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 64 GERMANY: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 65 GERMANY: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
9.3.2 UK
9.3.2.1 Market growth in the UK is driven by the increasing funding by public and private organizations
TABLE 66 UK: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 67 UK: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 68 UK: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 Rising prevalence of diabetes to support market growth
TABLE 69 FRANCE: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 70 FRANCE: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 71 FRANCE: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
9.3.4 ITALY
9.3.4.1 Increasing market availability of high-end bone growth stimulators to drive market growth
TABLE 72 ITALY: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 73 ITALY: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 74 ITALY: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 Growing geriatric population and the subsequent increase in the prevalence of target conditions to drive market growth
TABLE 75 SPAIN: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 76 SPAIN: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 77 SPAIN: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
9.3.6 REST OF EUROPE
TABLE 78 ROE: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 79 ROE: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 80 ROE: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 32 ASIA PACIFIC: BONE GROWTH STIMULATORS MARKET SNAPSHOT
TABLE 81 ASIA PACIFIC: BONE GROWTH STIMULATORS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 82 ASIA PACIFIC: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 83 ASIA PACIFIC: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 84 ASIA PACIFIC: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 85 ASIA PACIFIC: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 86 ASIA PACIFIC: BONE GROWTH STIMULATORS MARKET, BY END USER, 2019-2026 (USD MILLION)
9.4.1 JAPAN
9.4.1.1 Japan dominates the Asia Pacific bone growth stimulators market
TABLE 87 JAPAN: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 88 JAPAN: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 89 JAPAN: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
9.4.2 CHINA
9.4.2.1 Expansion in target patient population and modernization of healthcare facilities to drive the market growth
TABLE 90 CHINA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 91 CHINA: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 92 CHINA: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
9.4.3 INDIA
9.4.3.1 Growing number of orthopedic surgeries to support market growth
TABLE 93 INDIA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 94 INDIA: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 95 INDIA: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
9.4.4 AUSTRALIA
9.4.4.1 Availability of grants for the development of a comprehensive range of advanced treatments to support market growth
TABLE 96 AUSTRALIA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 97 AUSTRALIA: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 98 AUSTRALIA: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
9.4.5 SOUTH KOREA
9.4.5.1 Supportive government initiatives will positively impact market growth
TABLE 99 SOUTH KOREA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 100 SOUTH KOREA: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 101 SOUTH KOREA: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
9.4.6 REST OF ASIA PACIFIC
TABLE 102 ROAPAC: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 103 ROAPAC: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 104 ROAPAC: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
9.5 LATIN AMERICA
TABLE 105 LATIN AMERICA: BONE GROWTH STIMULATORS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 106 LATIN AMERICA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 107 LATIN AMERICA: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 108 LATIN AMERICA: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 109 LATIN AMERICA: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 110 LATIN AMERICA: BONE GROWTH STIMULATORS MARKET, BY END USER, 2019-2026 (USD MILLION)
9.5.1 BRAZIL
9.5.1.1 Modernization of healthcare facilities will drive market growth
TABLE 111 BRAZIL: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 112 BRAZIL: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 113 BRAZIL: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
9.5.2 MEXICO
9.5.2.1 Favorable investment scenario for medical device manufacturers to drive market growth
TABLE 114 MEXICO: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 115 MEXICO: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 116 MEXICO: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
9.5.3 REST OF LATIN AMERICA
TABLE 117 ROLATAM: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 118 ROLATAM: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 119 ROLATAM: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
9.6.1 AWARENESS INITIATIVES TO DRIVE THE ADOPTION OF BONE GROWTH STIMULATORS IN THE REGION
TABLE 120 MIDDLE EAST & AFRICA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 121 MIDDLE EAST & AFRICA: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 122 MIDDLE EAST & AFRICA: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 123 MIDDLE EAST & AFRICA: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 124 MIDDLE EAST & AFRICA: BONE GROWTH STIMULATORS MARKET, BY END USER, 2019-2026 (USD MILLION)
10 COMPETITIVE LANDSCAPE (Page No. - 164)
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
10.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN THE BONE GROWTH STIMULATORS MARKET
TABLE 125 OVERVIEW OF STRATEGIES DEPLOYED BY KEY BONE GROWTH STIMULATOR MANUFACTURING COMPANIES
10.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
FIGURE 33 REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE BONE GROWTH STIMULATORS MARKET
10.4 MARKET SHARE ANALYSIS
FIGURE 34 BONE GROWTH STIMULATORS MARKET SHARE, BY KEY PLAYER, 2020
10.5 COMPETITIVE SITUATIONS AND TRENDS
TABLE 126 BONE GROWTH STIMULATORS MARKET: DEGREE OF COMPETITION
10.6 COMPETITIVE LEADERSHIP MAPPING
10.7 VENDOR INCLUSION CRITERIA
10.7.1 STARS
10.7.2 EMERGING LEADERS
10.7.3 PERVASIVE PLAYERS
10.7.4 PARTICIPANTS
FIGURE 35 BONE GROWTH STIMULATORS MARKET: COMPETITIVE LEADERSHIP MAPPING (2020)
10.8 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES
10.8.1 PROGRESSIVE COMPANIES
10.8.2 STARTING BLOCKS
10.8.3 RESPONSIVE COMPANIES
10.8.4 DYNAMIC COMPANIES
FIGURE 36 BONE GROWTH STIMULATORS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES (2020)
10.9 FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE BONE GROWTH STIMULATORS MARKET
10.9.1 PRODUCT AND GEOGRAPHICAL FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE BONE GROWTH STIMULATORS MARKET
TABLE 127 COMPANY PRODUCT FOOTPRINT
TABLE 128 COMPANY REGIONAL FOOTPRINT
10.10 COMPETITIVE SCENARIO
10.10.1 PRODUCT LAUNCHES
TABLE 129 KEY PRODUCT LAUNCHES, JANUARY 2017-JUNE 2021
10.10.2 DEALS
TABLE 130 KEY DEALS, JANUARY 2017-JUNE 2021
10.10.3 OTHER DEVELOPMENTS
TABLE 131 OTHER DEVELOPMENTS, JANUARY 2017-JUNE 2021
11 COMPANY PROFILES (Page No. - 178)
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
11.1 KEY PLAYERS
11.1.1 ORTHOFIX MEDICAL, INC.
TABLE 132 ORTHOFIX MEDICAL, INC.: BUSINESS OVERVIEW
FIGURE 37 ORTHOFIX, MEDICAL INC.: COMPANY SNAPSHOT (2020)
11.1.2 DEPUY SYNTHES
TABLE 133 DEPUY SYNTHES: BUSINESS OVERVIEW
FIGURE 38 DEPUY SYNTHES: COMPANY SNAPSHOT (2020)
11.1.3 STRYKER
TABLE 134 STRYKER: BUSINESS OVERVIEW
FIGURE 39 STRYKER: COMPANY SNAPSHOT (2020)
11.1.4 BIOVENTUS LLC
TABLE 135 BIOVENTUS LLC: BUSINESS OVERVIEW
FIGURE 40 BIOVENTUS LLC: COMPANY SNAPSHOT (2020)
11.1.5 MEDTRONIC PLC
TABLE 136 MEDTRONIC PLC: BUSINESS OVERVIEW
FIGURE 41 MEDTRONIC PLC: COMPANY SNAPSHOT (2020)
11.1.6 DJO FINANCE, LLC
TABLE 137 DJO FINANCE, LLC: BUSINESS OVERVIEW
11.1.7 ZIMMER BIOMET
TABLE 138 ZIMMER BIOMET: BUSINESS OVERVIEW
FIGURE 42 ZIMMER BIOMET: COMPANY SNAPSHOT (2020)
11.1.8 ARTHREX, INC.
TABLE 139 ARTHREX, INC.: BUSINESS OVERVIEW
11.1.9 TERUMO CORPORATION
TABLE 140 TERUMO CORPORATION: BUSINESS OVERVIEW
FIGURE 43 TERUMO CORPORATION: COMPANY SNAPSHOT (2019)
11.1.10 OSSATEC BENELUX LTD.
TABLE 141 OSSATEC BENELUX LTD.: BUSINESS OVERVIEW
11.1.11 ISTO BIOLOGICS
TABLE 142 ISTO BIOLOGICS: BUSINESS OVERVIEW
11.1.12 EMBER THERAPEUTICS, INC.
TABLE 143 EMBER THERAPEUTICS, INC.: BUSINESS OVERVIEW
11.1.13 REGEN LAB SA
TABLE 144 REGEN LAB SA: BUSINESS OVERVIEW
11.1.14 ALTIS BIOLOGICS (PTY) LTD.
TABLE 145 ALTIS BIOLOGICS (PTY) LTD.: BUSINESS OVERVIEW
11.1.15 ITO CO., LTD.
TABLE 146 ITO CO., LTD.: BUSINESS OVERVIEW
11.2 OTHER COMPANIES
11.2.1 ELIZUR CORPORATION
11.2.2 BTT HEALTH GMBH
11.2.3 STIMULATE HEALTH
11.2.4 VQ ORTHOCARE
11.2.5 KINEX MEDICAL COMPANY, LLC
*Details on Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.
12 APPENDIX (Page No. - 210)
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 AVAILABLE CUSTOMIZATIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
